Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

9.0K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.0K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

7.5K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.5K
Abnormal Proliferation02:23

Abnormal Proliferation

4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

4.1K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.1K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

3.6K
The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Universal Phase Engineering of High-Entropy Sulfides for Stable Sodium-Ion Storage With Ultra-High Capacity and Ultra-Fast Kinetics.

Advanced materials (Deerfield Beach, Fla.)·2026
Same author

Tandem Catalysis Driven by Nitrogen Spillover in a Core-Shell Heterostructure for Direct Ammonia Fuel Cells.

Small (Weinheim an der Bergstrasse, Germany)·2026
Same author

TSG-6 exacerbates myocardial ischemia-reperfusion injury by activating NLRP3 inflammasome and regulating macrophage polarization.

Translational research : the journal of laboratory and clinical medicine·2026
Same author

Learn From Examples: In-Context Learning for Camouflaged Object Detection.

IEEE transactions on image processing : a publication of the IEEE Signal Processing Society·2026
Same author

Defects as Assets for Upcycling Spent Lithium-Ion Battery Cathode Materials.

Angewandte Chemie (International ed. in English)·2026
Same author

Ethylene Glycol-Assisted Interfacial Engineering for Efficient Electrocatalytic Nitrate Reduction to Ammonia at Industry-Relevant Current Exceeding 2 A cm<sup>-2</sup>.

ACS applied materials & interfaces·2026

Related Experiment Video

Updated: Jul 16, 2025

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer
09:08

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer

Published on: January 12, 2020

6.8K

Oncogenic MORC2 in cancer development and beyond.

Shan Zhang1, Ayao Guo2, Huan Wang1

  • 1Key Laboratory of Cell Biology, Department of Cell Biology, Ministry of Public Health and Key Laboratory of Medical Cell Biology, Ministry of Education, China Medical University, Shenyang, Liaoning 110122, China.

Genes & Diseases
|September 11, 2023
PubMed
Summary

Microrchidia CW-type zinc finger 2 (MORC2) is a nuclear protein involved in gene regulation and cancer development. This review summarizes MORC2's role in cancer hallmarks, therapeutic resistance, and its upstream/downstream targets for potential clinical applications.

Keywords:
Cancer developmentHallmarks of cancerMORC2Therapeutic targetTreatment resistance

More Related Videos

In Vitro Establishment of a Genetically Engineered Murine Head and Neck Cancer Cell Line using an Adeno-Associated Virus-Cas9 System
05:45

In Vitro Establishment of a Genetically Engineered Murine Head and Neck Cancer Cell Line using an Adeno-Associated Virus-Cas9 System

Published on: January 9, 2020

8.0K
Modeling Oral-Esophageal Squamous Cell Carcinoma in 3D Organoids
10:43

Modeling Oral-Esophageal Squamous Cell Carcinoma in 3D Organoids

Published on: December 23, 2022

3.4K

Related Experiment Videos

Last Updated: Jul 16, 2025

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer
09:08

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer

Published on: January 12, 2020

6.8K
In Vitro Establishment of a Genetically Engineered Murine Head and Neck Cancer Cell Line using an Adeno-Associated Virus-Cas9 System
05:45

In Vitro Establishment of a Genetically Engineered Murine Head and Neck Cancer Cell Line using an Adeno-Associated Virus-Cas9 System

Published on: January 9, 2020

8.0K
Modeling Oral-Esophageal Squamous Cell Carcinoma in 3D Organoids
10:43

Modeling Oral-Esophageal Squamous Cell Carcinoma in 3D Organoids

Published on: December 23, 2022

3.4K

Area of Science:

  • Molecular Biology
  • Oncology
  • Genetics

Background:

  • Microrchidia CW-type zinc finger 2 (MORC2) is a nuclear protein belonging to the MORC superfamily.
  • MORC2 is implicated in crucial cellular processes including gene transcription and chromatin remodeling.
  • Dysregulation of MORC2 is increasingly linked to human diseases and cancer progression.

Purpose of the Study:

  • To provide an updated overview of MORC2's role in cancer hallmarks and therapeutic resistance.
  • To summarize the known upstream regulators and downstream target genes of MORC2.
  • To offer a theoretical basis for understanding MORC2's function in tumor development and its clinical potential.

Main Methods:

  • Systematic literature review.
  • Analysis of existing research on MORC2 function in cancer.
  • Compilation of data on MORC2's regulatory networks.

Main Results:

  • MORC2 influences key cancer hallmarks.
  • MORC2 plays a role in the development of therapeutic resistance.
  • MORC2 regulates the expression of critical oncogenes and tumor suppressors.

Conclusions:

  • MORC2 is a significant factor in tumor development and progression.
  • Understanding MORC2's regulatory network is crucial for cancer research.
  • MORC2 represents a potential therapeutic target for cancer treatment.